Dabrafenib + Trametinib + PDR001 In Colorectal Cancer
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This research study is studying a combination of drugs as a possible treatment for metastatic
colorectal cancer characterized by BRAF V600E mutation.
The names of the study drugs involved in this study are:
- Dabrafenib
- Trametinib
- PDR001